Identification and Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning Pathway

NAActive, not recruitingINTERVENTIONAL
Enrollment

19,916

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

March 20, 2024

Study Completion Date

October 31, 2025

Conditions
Acute Respiratory Distress SyndromeHypoxemic Respiratory FailureARDS, Human
Interventions
OTHER

TheraPPP

"TheraPPP Steps:~Step 1. All mechanically ventilated patients will have a height measured and documented. Step 2. Screening for HRF. Step 3. Initiate Lung Protective Ventilation (LPV). Step 4. Paralysis. Step 5. Prone Positioning."

Trial Locations (17)

T1Y 6J4

Peter Lougheed Centre (PLC), Calgary

T2N 2T9

Foothills Hospital Intensive Care Unit, Calgary

Foothills Medical Center Cardiovascular ICU, Calgary

T2V 1P9

Rockyview General Hospital, Calgary

T3M 1M4

South Health Campus, Calgary

T5H 3V9

Royal Alexandra Hospital, Edmonton

T5R 4H5

Misericordia Community Hospital, Edmonton

T6G 2B7

Mazankowski Alberta Heart Institute, Edmonton

University of Alberta Hospital General Systems ICU, Edmonton

University of Alberta Hospital Neurosciences Intensive Care Unit, Edmonton

T6L 5X8

Grey Nuns Community Hospital, Edmonton

T9H 1P2

Northern Lights Regional Health Centre, Fort McMurray

T8V 2E8

Queen Elizabeth II Hospital, Grande Prairie

T1J 1W5

Chinook Regional Hospital, Lethbridge

T1A 4H6

Medicine Hat Regional Hospital, Medicine Hat

T4N 4E7

Red Deer Regional Hospital Centre, Red Deer

T8N 6C4

Sturgeon Community Hospital, St. Albert

All Listed Sponsors
collaborator

Alberta Health services

OTHER

lead

University of Calgary

OTHER